Juliet Cunningham
Vice President of Investor Relations
Replay available
QuidelOrtho Corporation (NASDAQ: QDEL) Q2 2025 earnings conference call, held 2025-08-05. Replay captured from the company's public earnings webcast.

Vice President of Investor Relations
President and Chief Executive Officer
Chief Financial Officer
Analyst, William Blair & Company
Analyst, Citi
Analyst, RBC Capital Markets
Analyst, J.P. Morgan
Analyst, New Front Research
Analyst, Raymond James
So also second quarter, 2025 financial results conference call and webcast. At this time, all participant lines are in a listen only mode. For those of you participating in this conference call, there will be an opportunity for your questions at the end of today's prepared remarks. Please note this conference call is being recorded and audio replay of this conference call will be available on companies webcast shortly after this call. I would now like to turn the call over to Juliet Cunningham, the vice president of investor relations. Please proceed. Thank you. Good afternoon, everyone, and thanks for joining the Quite Out Ortho second quarter, 2025 financial results conference call. Joining me today are Brian Blazer, president and chief executive officer, and Joe Buskey, chief financial officer. This conference call is being simultaneously webcast on the investor relations page or website. To aid in the presentation, we have also posted supplemental information on the investor relations page that will be referenced throughout this call. This conference call and supplemental information contain forward-looking statements within the meaning of the Private Security Litigation Reform Act of 1995. Statements that are not historically, strictly historical, including the company's expectations, plans, financial guidance, and future performance, as well as prospects, are forward-looking statements that are subject to certain risks, uncertainties, assumptions, and other factors. This includes the expected impact of tariffs and macroeconomic conditions and the proposed acquisition of RECs diagnostics. Actual results may vary materially from those expressed or implied in these forward-looking statements. Information about potential factors that could affect our actual results...